Home
News
Create
Screeners
Insights
Transgene Biotek
2.
68
+0.14
(+5.51%)
Market Cap
₹20.36 Cr
PE Ratio
-10.16
Industry
Healthcare Services
Buy
Sell
Company Performance:
1D
+5.51%
1M
+8.94%
6M
-39.09%
1Y
-36.94%
5Y
-30.93%
View Company Insights
Latest news about Transgene Biotek
Transgene Biotek Limited Reports Q3 FY26 Net Loss of ₹37.38 Lakhs
10 days ago
Transgene Biotek Limited reported a net loss of ₹37.38 lakhs for Q3 FY26 ended December 31, 2025, significantly higher than the ₹8.90 lakhs loss in Q3 FY25. Revenue from operations declined 28.76% to ₹5.45 lakhs, while total expenses more than doubled to ₹42.82 lakhs, primarily due to finance costs surging to ₹27.35 lakhs. For the nine-month period, the company posted a loss of ₹119.59 lakhs against a profit of ₹3.70 lakhs in the previous year.
Transgene Biotech Limited Faces SEBI Recovery Proceedings Over Rs.38 Lacs Penalty Default
Feb 03, 2026
Transgene Biotek Reports Net Loss and Approves Key Board Decisions
Nov 14, 2025
Transgene Biotek Faces Legal Challenge at NCLT Over Rs 6.82 Crore Unpaid Loan
Oct 17, 2025
Transgene Biotek Reports Q1 Loss, Appoints New Auditors Amid Ongoing Regulatory Challenges
Aug 07, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation